23andMe bought by Regeneron in court auction.

Regeneron has agreed to buy 23andMe and all of its assets for 256 million. This purchase marks the end of former 23andme CEO Anne Wojcicki's bid to buy the company. The company has taken a dramatic fall in recent years.